Myaing M. Nyunt
University of Maryland, Baltimore
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Myaing M. Nyunt.
PLOS Medicine | 2011
Pedro L. Alonso; Quique Bassat; Fred Binka; T Brewer; R Chandra; J. Culpepper; Rhoel R. Dinglasan; K Duncan; S Duparc; Mark M. Fukuda; R Laxminarayan; MacArthur; Magill A; C Marzetta; J. Milman; T Mutabingwa; François Nosten; S Nwaka; Myaing M. Nyunt; C Ohrt; Christopher V. Plowe; J Pottage; Ric N. Price; Pascal Ringwald; A. Serazin; Dennis Shanks; Robert E. Sinden; Marcel Tanner; H Vial; Sa Ward
The Malaria Eradication Research Agenda (malERA) Consultative Group on Drugs present a research and development agenda to ensure that appropriate drugs are available for use in malaria eradication.
The Journal of Infectious Diseases | 2015
Shannon Takala-Harrison; Christopher G. Jacob; Cesar Arze; Michael P. Cummings; Joana C. Silva; Arjen M. Dondorp; Mark M. Fukuda; Tran Tinh Hien; Mayfong Mayxay; Harald Noedl; François Nosten; Myat Phone Kyaw; Nguyen Thanh Thuy Nhien; Mallika Imwong; Delia Bethell; Youry Se; Chanthap Lon; Stuart D. Tyner; David L. Saunders; Frédéric Ariey; Odile Mercereau-Puijalon; Didier Ménard; Paul N. Newton; Maniphone Khanthavong; Bouasy Hongvanthong; Peter Starzengruber; Hans-Peter Fuehrer; Paul Swoboda; Wasif Ali Khan; Aung Pyae Phyo
BACKGROUND The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia. METHODS P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33 716 genome-wide single-nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance, and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread or whether they emerged independently. RESULTS The presence of nonreference K13 alleles was associated with prolonged parasite clearance half-life (P = 1.97 × 10(-12)). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas. CONCLUSIONS K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.
The Journal of Infectious Diseases | 2014
Shannon Takala-Harrison; Christopher G. Jacob; Cesar Arze; Michael P. Cummings; Joana C. Silva; Arjen M. Dondorp; Mark M. Fukuda; Tran Tinh Hien; Mayfong Mayxay; Harald Noedl; François Nosten; Myat Phone Kyaw; Nguyen Thanh Thuy Nhien; Mallika Imwong; Delia Bethell; Youry Se; Chanthap Lon; Stuart D. Tyner; David L. Saunders; Frédéric Ariey; Odile Mercereau-Puijalon; Didier Ménard; Paul N. Newton; Maniphone Khanthavong; Bouasy Hongvanthong; Peter Starzengruber; Hans-Peter Fuehrer; Paul Swoboda; Wasif Ali Khan; Aung Pyae Phyo
BACKGROUND The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia. METHODS P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33 716 genome-wide single-nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance, and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread or whether they emerged independently. RESULTS The presence of nonreference K13 alleles was associated with prolonged parasite clearance half-life (P = 1.97 × 10(-12)). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas. CONCLUSIONS K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.
PLOS ONE | 2013
Myat Phone Kyaw; Myat Htut Nyunt; Khin Chit; Moe M. Aye; Kyin Hla Aye; Niklas Lindegardh; Joel Tarning; Mallika Imwong; Christopher G. Jacob; Charlotte Rasmussen; Jamie Perin; Pascal Ringwald; Myaing M. Nyunt
Background Plasmodium falciparum resistance to artemisinins, the first line treatment for malaria worldwide, has been reported in western Cambodia. Resistance is characterized by significantly delayed clearance of parasites following artemisinin treatment. Artemisinin resistance has not previously been reported in Myanmar, which has the highest falciparum malaria burden among Southeast Asian countries. Methods A non-randomized, single-arm, open-label clinical trial of artesunate monotherapy (4 mg/kg daily for seven days) was conducted in adults with acute blood-smear positive P. falciparum malaria in Kawthaung, southern Myanmar. Parasite density was measured every 12 hours until two consecutive negative smears were obtained. Participants were followed weekly at the study clinic for three additional weeks. Co-primary endpoints included parasite clearance time (the time required for complete clearance of initial parasitemia), parasite clearance half-life (the time required for parasitemia to decrease by 50% based on the linear portion of the parasite clearance slope), and detectable parasitemia 72 hours after commencement of artesunate treatment. Drug pharmacokinetics were measured to rule out delayed clearance due to suboptimal drug levels. Results The median (range) parasite clearance half-life and time were 4.8 (2.1–9.7) and 60 (24–96) hours, respectively. The frequency distributions of parasite clearance half-life and time were bimodal, with very slow parasite clearance characteristic of the slowest-clearing Cambodian parasites (half-life longer than 6.2 hours) in approximately 1/3 of infections. Fourteen of 52 participants (26.9%) had a measurable parasitemia 72 hours after initiating artesunate treatment. Parasite clearance was not associated with drug pharmacokinetics. Conclusions A subset of P. falciparum infections in southern Myanmar displayed markedly delayed clearance following artemisinin treatment, suggesting either emergence of artemisinin resistance in southern Myanmar or spread to this location from its site of origin in western Cambodia. Resistance containment efforts are underway in Myanmar. Trial Registration Australian New Zealand Clinical Trials Registry ACTRN12610000896077
The Journal of Infectious Diseases | 2015
Fang Huang; Shannon Takala-Harrison; Christopher G. Jacob; Hui Liu; Xiaodong Sun; Heng-Lin Yang; Myaing M. Nyunt; Matthew Adams; Zhou Ss; Zhi-Gui Xia; Pascal Ringwald; Maria Dorina G. Bustos; Tang Lh; Christopher V. Plowe
BACKGROUND Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and poses a threat to malaria control and elimination. Mutations in a P. falciparum gene encoding a kelch protein on chromosome 13 have been associated with delayed parasite clearance following artemisinin treatment elsewhere in the region, but not yet in China. METHODS Therapeutic efficacy studies of artesunate and dihydroartemisinin-piperaquine were conducted from 2009 to 2012 in the Yunnan Province of China near the border with Myanmar. K13 mutations were genotyped by capillary sequencing of DNA extracted from dried blood spots collected in these clinical trials and in routine surveillance. Associations between K13 mutations and delayed parasite clearance were tested using regression models. RESULTS Parasite clearance half-lives were prolonged after artemisinin treatment, with 44% of infections having half-lives >5 hours (n = 109). Fourteen mutations in K13 were observed, with an overall prevalence of 47.7% (n = 329). A single mutation, F446I, predominated, with a prevalence of 36.5%. Infections with F446I were significantly associated with parasitemia on day 3 following artemisinin treatment and with longer clearance half-lives. CONCLUSIONS Plasmodium falciparum infections in southern China displayed markedly delayed clearance following artemisinin treatment. F446I was the predominant K13 mutation and was associated with delayed parasite clearance.
Clinical Pharmacology & Therapeutics | 2010
Myaing M. Nyunt; I Adam; Kassoum Kayentao; J.G. van Dijk; Phil E. Thuma; K Mauff; Francesca Little; Yasmin Cassam; Etienne A. Guirou; B Traore; Ogobara K. Doumbo; David J. Sullivan; Peter J. Smith; Karen I. Barnes
Malaria during pregnancy is associated with maternal and fetal morbidity and mortality. In order to minimize the burden, sulfadoxine–pyrimethamine (SP) is widely used in Africa as an intermittent preventive treatment of malaria in pregnancy (IPTp). However, only limited data are available on the pharmacokinetics of sulfadoxine and pyrimethamine during pregnancy. We conducted a prospective, self‐matched, multicenter study of 98 pregnant women in four African countries in order to determine the effects of pregnancy on SP pharmacokinetics. After adjusting for the effects of potential confounders, blood concentrations (associated with therapeutic efficacy) of pyrimethamine were higher (geometric mean ratio (GMR) 1.33; 95% confidence interval (CI) 1.18–1.51; P < 0.001) and those of sulfadoxine were lower (GMR 0.91; 95% CI 0.84–0.98; P = 0.013) on day 7 after SP administration during pregnancy than after the postpartum period. SP pharmacokinetic parameters differed significantly among the study sites. Given the inconsistency of changes in pharmacokinetic parameters between sulfadoxine and pyrimethamine as well as among the study sites, it is not possible to recommend any dose adjustment to prolong the therapeutic life span of the fixed dose combination of SP for IPTp on the basis of our study findings.
Clinical Pharmacology & Therapeutics | 2007
Myaing M. Nyunt; Christopher V. Plowe
Combination drug therapy for malaria is recommended both to prevent and to overcome drug resistance. Drug combinations developed for use in Asia are being deployed in Africa, where higher rates of malaria affect the therapeutic and public health objectives of malaria chemotherapy as well as drug safety. Rational consideration of drug mechanisms, pharmacokinetics (PK), pharmacodynamics (PD), and malaria epidemiology should result in more effective combination regimens that retain therapeutic and prophylactic efficacy in the face of resistance.
Malaria Journal | 2013
Chai Shawi Prue; Kerry L. Shannon; Jacob Khyang; Laura J Edwards; Sabeena Ahmed; Malathi Ram; Timothy Shields; Mohammad Sharif Hossain; Gregory E. Glass; Myaing M. Nyunt; David A. Sack; David J. Sullivan; Wasif Ali Khan
BackgroundThe recent introduction of mobile phones into the rural Bandarban district of Bangladesh provided a resource to improve case detection and treatment of patients with malaria.MethodsDuring studies to define the epidemiology of malaria in villages in south-eastern Bangladesh, an area with hypoendemic malaria, the project recorded 986 mobile phone calls from families because of illness suspected to be malaria between June 2010 and June 2012.ResultsBased on phone calls, field workers visited the homes with ill persons, and collected blood samples for malaria on 1,046 people. 265 (25%) of the patients tested were positive for malaria. Of the 509 symptomatic malaria cases diagnosed during this study period, 265 (52%) were detected because of an initial mobile phone call.ConclusionMobile phone technology was found to be an efficient and effective method for rapidly detecting and treating patients with malaria in this remote area. This technology, when combined with local knowledge and field support, may be applicable to other hard-to-reach areas to improve malaria control.
Malaria Journal | 2011
Wasif Ali Khan; David A. Sack; Sabeena Ahmed; Chai Shawi Prue; Mohammad Shafiul Alam; Rashidul Haque; Jacob Khyang; Malathi Ram; Jasmin Akter; Myaing M. Nyunt; Douglas E. Norris; Gregory E. Glass; Timothy Shields; Zahirul Haq; Alejandro Cravioto; David J. Sullivan
BackgroundUntil recently the Chittagong Hill tracts have been hyperendemic for malaria. A past cross-sectional RDT based survey in 2007 recorded rates of approximately 15%. This study was designed to understand the present epidemiology of malaria in this region, to monitor and facilitate the uptake of malaria intervention activities of the national malaria programme and to serve as an area for developing new and innovative control strategies for malaria.MethodsThis research field area was established in two rural unions of Bandarban District of Bangladesh north of Bandarban city, which are known to be endemic for malaria due to Plasmodium falciparum. The project included the following elements: a) a demographic surveillance system including an initial census with updates every four months, b) periodic surveys of knowledge attitude and practice, c) a geographic information system, d) weekly active and continuous passive surveillance for malaria infections using smears, rapid tests and PCR, f) monthly mosquito surveillance, and e) daily weather measures. The programme included both traditional and molecular methods for detecting malaria as well as lab methods for speciating mosquitoes and detecting mosquitoes infected with sporozoites.ResultsThe demographic surveillance enumerated and mapped 20,563 people, 75% of which were tribal non-Bengali. The monthly mosquito surveys identified 22 Anopheles species, eight of which were positive by circumsporozoite ELISA. The annual rate of malaria was close to 1% with 85% of cases in the rainy months of May-October. Definitive clustering identified in the low transmission season persisted during the high transmission season.ConclusionThis demographically and geographically defined area, near to the Myanmar border, which is also hypoendemic for malaria, will be useful for future studies of the epidemiology of malaria and for evaluation of strategies for malaria control including new drugs and vaccines.
PLOS ONE | 2013
Sabeena Ahmed; Sean Galagan; Heather Scobie; Jacob Khyang; Chai Shwai Prue; Wasif Ali Khan; Malathi Ram; Mohammad Shafiul Alam; M. Zahirul Haq; Jasmin Akter; Gregory E. Glass; Douglas E. Norris; Myaing M. Nyunt; Timothy Shields; David J. Sullivan; David A. Sack
Background Malaria is endemic in 13 of 64 districts of Bangladesh, representing a population at risk of about 27 million people. The highest rates of malaria in Bangladesh occur in the Chittagong Hill Districts, and Plasmodium falciparum (predominately chloroquine resistant) is the most prevalent species. Methods The objective of this research was to describe the epidemiology of symptomatic P. falciparum malaria in an area of Bangladesh following the introduction of a national malaria control program. We carried out surveillance for symptomatic malaria due to P. falciparum in two demographically defined unions of the Chittagong Hill Districts in Bangladesh, bordering western Myanmar, between October 2009 and May 2012. The association between sociodemographics and temporal and climate factors with symptomatic P. falciparum infection over two years of surveillance data was assessed. Risk factors for infection were determined using a multivariate regression model. Results 472 cases of symptomatic P. falciparum malaria cases were identified among 23,372 residents during the study period. Greater than 85% of cases occurred during the rainy season from May to October, and cases were highly clustered geographically within these two unions with more than 80% of infections occurring in areas that contain approximately one-third of the total population. Risk factors statistically associated with infection in a multivariate logistic regression model were living in the areas of high incidence, young age, and having an occupation including jhum cultivation and/or daily labor. Use of long lasting insecticide-treated bed nets was high (89.3%), but its use was not associated with decreased incidence of infection. Conclusion Here we show that P. falciparum malaria continues to be hypoendemic in the Chittagong Hill Districts of Bangladesh, is highly seasonal, and is much more common in certain geographically limited hot spots and among certain occupations.